An endoplasmic reticulum stress-related signature could robustly predict prognosis and closely associate with response to immunotherapy in pancreatic ductal adenocarcinoma.
暂无分享,去创建一个
Lishan Fang | Zishan Xie | Shuguang Liu | Nali Quan | Qianying Hu | Shaojing Chen | Yixuan Li | Kaimeng Huang | Riqing Li
[1] D. Munn,et al. Ablation of the endoplasmic reticulum stress kinase PERK induces paraptosis and type I interferon to promote anti-tumor T cell responses. , 2022, Cancer cell.
[2] Wei-Lin Jin,et al. Reclassification of Hepatocellular Cancer With Neural-Related Genes , 2022, Frontiers in Oncology.
[3] Jinfeng Zhu,et al. Identification of LncRNA Prognostic Signature Associated With Genomic Instability in Pancreatic Adenocarcinoma , 2022, Frontiers in Oncology.
[4] M. Hiramoto,et al. Lysosome-targeted drug combination induces multiple organelle dysfunctions and non-canonical death in pancreatic cancer cells , 2021, Oncology reports.
[5] S. Koyama,et al. Mechanisms of regulatory T cell infiltration in tumors: implications for innovative immune precision therapies , 2021, Journal for ImmunoTherapy of Cancer.
[6] N. Mishra,et al. Pan-Cancer Analysis of Human Kinome Gene Expression and Promoter DNA Methylation Identifies Dark Kinase Biomarkers in Multiple Cancers , 2021, Cancers.
[7] S. Pauklin,et al. TGFB1/INHBA homodimer/Nodal-SMAD2/3 Signalling Network: A Pivotal Molecular Target in PDAC Treatment. , 2021, Molecular therapy : the journal of the American Society of Gene Therapy.
[8] Afshin Samali,et al. An Emerging Role for the Unfolded Protein Response in Pancreatic Cancer , 2021, Cancers.
[9] A. Jemal,et al. Cancer Statistics, 2021 , 2021, CA: a cancer journal for clinicians.
[10] Xi Chen,et al. Endoplasmic reticulum stress signals in the tumour and its microenvironment , 2020, Nature Reviews Cancer.
[11] Xianjun Yu,et al. Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma , 2020, Journal of Hematology & Oncology.
[12] T. Rana,et al. m6A RNA methyltransferases METTL3/14 regulate immune responses to anti‐PD‐1 therapy , 2020, The EMBO journal.
[13] P. Ohashi,et al. The Roles of CD8+ T Cell Subsets in Antitumor Immunity. , 2020, Trends in cell biology.
[14] E. O’Reilly,et al. New Treatment Strategies for Metastatic Pancreatic Ductal Adenocarcinoma , 2020, Drugs.
[15] Myung Ah Lee,et al. Durvalumab With or Without Tremelimumab for Patients With Metastatic Pancreatic Ductal Adenocarcinoma: A Phase 2 Randomized Clinical Trial. , 2019, JAMA oncology.
[16] C. Sautès-Fridman,et al. Tertiary lymphoid structures in the era of cancer immunotherapy , 2019, Nature Reviews Cancer.
[17] K. Olive,et al. Enhancing responsiveness of pancreatic cancer cells to gemcitabine treatment under hypoxia by heme oxygenase‐1 inhibition , 2019, Translational research : the journal of laboratory and clinical medicine.
[18] Bas Groot Koerkamp,et al. International Validation of the Eighth Edition of the American Joint Committee on Cancer (AJCC) TNM Staging System in Patients With Resected Pancreatic Cancer , 2018, JAMA surgery.
[19] Miao Yin,et al. CARM1 Methylates GAPDH to Regulate Glucose Metabolism and Is Suppressed in Liver Cancer. , 2018, Cell reports.
[20] J. García-Foncillas,et al. New Hope for Pancreatic Ductal Adenocarcinoma Treatment Targeting Endoplasmic Reticulum Stress Response: A Systematic Review , 2018, International journal of molecular sciences.
[21] X. Liu,et al. Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response , 2018, Nature Medicine.
[22] Joshua M. Stuart,et al. Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation. , 2018, Cell.
[23] Judith A. Smith. Regulation of Cytokine Production by the Unfolded Protein Response; Implications for Infection and Autoimmunity , 2018, Front. Immunol..
[24] Wei‐Chao Chang,et al. Heme oxygenase-1 mediates BAY 11-7085 induced ferroptosis. , 2018, Cancer letters.
[25] C. Iacobuzio-Donahue,et al. Unresolved endoplasmic reticulum stress engenders immune-resistant, latent pancreatic cancer metastases , 2017, Science.
[26] Z. Nwosu,et al. Caveolin-1 in the regulation of cell metabolism: a cancer perspective , 2016, Molecular Cancer.
[27] D. Rades,et al. Dasatinib blocks transcriptional and promigratory responses to transforming growth factor-beta in pancreatic adenocarcinoma cells through inhibition of Smad signalling: implications for in vivo mode of action , 2015, Molecular Cancer.
[28] Hyun-Jong Cho,et al. Elevated endoplasmic reticulum stress reinforced immunosuppression in the tumor microenvironment via myeloid-derived suppressor cells , 2014, Oncotarget.
[29] R. Kaufman,et al. The impact of the endoplasmic reticulum protein-folding environment on cancer development , 2014, Nature Reviews Cancer.
[30] Jianhua Zhang,et al. Cellular metabolic and autophagic pathways: traffic control by redox signaling. , 2013, Free radical biology & medicine.
[31] K. Pantel,et al. Discovery of a novel unfolded protein response phenotype of cancer stem/progenitor cells from the bone marrow of breast cancer patients. , 2010, Journal of proteome research.
[32] K. Wakasa,et al. HER2 overexpression correlates with survival after curative resection of pancreatic cancer , 2009, Cancer science.
[33] G. Kroemer,et al. Organelle-specific initiation of cell death pathways , 2001, Nature Cell Biology.